Please try another search
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK250 million ($23.49 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Torgny H. Svensson | - | - | Member of Scientific Advisory Board |
David Jern | 50 | 2021 | Independent Director |
Staffan Nilsson | 73 | - | Member of Scientific Advisory Board |
Karl-Olov Fagerström | - | - | Member of Scientific Advisory Board |
Malin Enarson | 50 | 2023 | Independent Director |
Holland Cheng | - | - | Member of Scientific Advisory Board |
Karl Tobieson | 49 | 2008 | Chairman |
Gunnar Kratz | - | - | Member of Scientific Advisory Board |
Lena Söderström | 63 | 2022 | Independent Director |
Anna Torner | 59 | 2022 | Independent Director |
Otto Ankarcrona | 52 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review